Eisai (United States)
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Eisai (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
46%
Total
Publications
2.1K
Total Open
Publications
956
Total
Citations
74K
Open Access
Percentage
46%
Total
Publications
2.1K
Total Open
Publications
956
Total
Citations
74K
Breakdown
Publisher Open
18%
Both
23%
Other Platform Open
4%
Closed
55%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 33%
275
Hybrid 35%
298
No Guarantees 32%
265
Other Platform Open
Domain 82%
467
Institution 18%
101
Other Internet 15%
84
Preprint 2%
12
Public 2%
11
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 467 |
DOI | Other Internet | 83 |
Europe PMC | Domain | 21 |
Royal Netherlands Academy of Arts and Sciences | Institution | 16 |
Yonsei University | Institution | 11 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 11 |
Figshare | Public | 10 |
bioRxiv | Preprint | 9 |
University of Melbourne | Institution | 7 |
Istituto di Ematologia di Bologna | Institution | 7 |